Self-assembly of a helical zinc-europium complex: speciation in aqueous solution and luminescence.

Two new tridentate(NNO)-bidentate(NN) compartmental ligands, HL(5) and HL(6), are synthesized from pyridine and benzimidazole synthons. They react in aqueous solution under physiological conditions with Zn(II), Ln(III), or a mixture thereof, to yield complexes of different stoichiometries, 1:3, 2:2, 2:3, 1:1:3, the speciation of which is established by UV-visible titrations and ESI mass spectrometry. Photophysical studies of the Eu(III)-containing solutions in Tris-HCl 0.1 M (pH = 7.4) show that lanthanide luminescence arises from a unique N6O3 coordination site with pseudo D 3 symmetry. Relevant parameters such as crystal field splitting, lifetime, radiative lifetime, and intrinsic quantum yield perfectly match those reported for dinuclear 4f-4f helicates in which the Eu(III) ion has the same coordination environment.

Introduction

Helical structures have attracted chemists' attention when Linus Pauling published a seminal series of papers at the beginning of the 1950's dealing with the secondary structures of proteins induced by three-dimensional helical patterns (Pauling et al., 1951). The demonstration that helical structures can also be engineered at the molecular level by taking advantage of stereochemical properties of n class="Chemical">metal ions had to wait until 1987 when Jean-Marie Lehn isolated 3:2 CuI:L double-stranded helical complexes that he named helicates, where L is an oligo-bipyridine ligand (Lehn et al., 1987). A few years later, Claude Piguet applied the same concept to trivalent lanthanide ions and successfully self-assembled the first LnIII dinuclear triple-stranded helicate, [Eu2(LA)3]6+ (Scheme 1), the crystal structure of which evidences a stabilization of the molecular architecture by π−π stacking interactions between the ligand strands (Bernardinelli et al., 1992). The two 9-coordinate metal ions lie on a pseudo-C3 axis of symmetry (Figure 1); in solution the average symmetry of the edifice is D3 on NMR time scale (Piguet et al., 1993). This initial work paved the way for the development of several series of lanthanide polynuclear and polymetallic complexes including heterobimetallic nd-4f (Piguet et al., 1995a) and 4f-4f′ (André et al., 2004) chelates, as well as tri- and tetranuclear homometallic and heterometallic entities (Piguet et al., 2000; Piguet and Bünzli, 2010). Interestingly, the helicates are quite stable in solution despite large Coulomb repulsion between two neighboring cations which lie about 9 Å apart; careful thermodynamic considerations for 3d-4f and 4f-4f-4f helicates indeed show that the cation-cation repulsive energy (≈700 kJ·mol−1) is largely compensated by favorable solvation energy (Canard and Piguet, 2007). Furthermore, soluble helicates [Ln2(LC1)3] can be assembled in water and are highly stable, with logβ23 on the order of 26–30 (Elhabiri et al., 1998). Crystal structures revealed triple-stranded helicates with 9-coordinate metal ions (Ln = Eu, Tb) well-imbedded into the edifice and displaying interesting photophysical properties (Elhabiri et al., 1998; Gonçalves e Silva et al., 2002). Subsequent molecular engineering led to the series of the more water-soluble [Ln2(LC2)3] helicates and their bioconjugates which proved to be adequate luminescent bioprobes for live cell staining (Song et al., 2008; Chauvin et al., 2013) and for specific detection of biomarkers expressed by cancerous cells (Fernandez-Moreira et al., 2010).

Scheme 1

Molecular structure of some ditopic ligands used for self-assembling dinuclear helicates.

Figure 1

Side and top views of the molecular structure of [Eu Redrawn from data in Bernardinelli et al. (1992).

One fascinating aspect of the polymetallic helical molecular edifices is the possibility of controlling the optical and/or magnetic properties of one ion by the other, through communication along the pseudo C3 axis. Examples are the tuning of the spin-crossover temperature in [FeLn(L1,2)3]5+ (Piguet et al., 1995b; Edder et al., 2000, 2001), (Scheme 1) or the lengthening of the excited state lifetimes of n class="Chemical">NdIII and YbIII in [CrLn(L1)3]6+ (Torelli et al., 2005). Such tunability would be of great help in the design of specific biosensors and stains, especially that [EuZn(L2)3]5+ proved to be quite luminescent in water with a quantum yield of 15% (Edder et al., 1997; Piguet and Bünzli, 2010). Bioprobes need to be water soluble and amenable to bioconjugation; unfortunately, helicates with the carboxylic acid derivatives HL3 and HL4 do not show enough water solubility for this purpose. In this paper, we apply to HL3 the successful strategy used in going from H2LC1 to H2LC2 in the hope of gaining access to luminescent and soluble 3d-4f helicates with ligands HL5 and HL6. More specifically, and as a first step toward engineering bioprobes based on such compounds, complex formation in the EuIII-ZnII-HL6 system and associated luminescent properties are investigated. Spectroscopically silent ZnII has been chosen because it allows studying the coordination environment of the EuIII ion without interference from the MII ion.

Results and discussion

Ligand synthesis

The underlying principle of the synthesis of HL5 and HL6 is the same as the one adopted for preparing ligands L1, 2 (Edder et al., 2000), and HL3 (Edder et al., 1997), namely a multistep strategy based on a modified Phillips reaction for the formation of the n class="Chemical">benzimidazole rings. However, the diethylamino groups are replaced by 2-[2-(2-methoxyethoxy)ethoxy]-N-{2-[2-(2-methoxyethoxy)ethoxy]ethyl}-ethanamino groups. Following our previous work (Deiters et al., 2009), the latter have been grafted on the key intermediate (6), the synthesis of which is depicted on Scheme 2 while the routes for accessing ligands HL5 and HL6 are summarized on Scheme 3. Regarding sulfonation, the absence of directional electronic effects favoring electrophilic substitution in the ditopic ligands and the large number of carbon atoms amenable to sulfonation implies that the corresponding group has to be inserted in one of the starting building blocks, namely (3).

Scheme 2

Synthesis of the new precursor (6): (i) CH.

Scheme 3

Synthesis of HL.

Intermediate (6) was prepared in 7 steps and 23% yield from commercially available 2-picoline, n class="Chemical">benzylamine and triethylene glycol monomethyl ether (TEGOMe). The first two steps involve the synthesis of 2-[2-(2-methoxyethoxy)ethoxy]-N-{2-[2-(2-methoxyethoxy)-ethoxy]ethyl}ethanamine (2): two TEGOMe arms are grafted on the primary benzylamine by reaction with BrTEGOMe in presence of a weak base (reaction i, Scheme 2) followed by selective and quantitative cleavage of the benzylamino group by continuous flow hydrogenation (reaction ii). Two other steps are necessary for preparing (3) from 2-picoline by treatment with oleum and subsequent oxidation with permanganate, according to a previously described procedure (Delarge, 1965). The sulfonate function of (3) is then activated by chlorination (reaction iii), in presence of a PCl5/POCl3 mixture to give the corresponding sulfonyl chloride (4). Coupling between (2) and (4) is subsequently achieved under standard conditions (reaction iv) to yield sulfonamide (5). Finally, oxidation of the methyl group of (5) into a carboxy group conducted in presence of an excess of SeO2 in refluxing pyridine affords synthon (6) in almost quantitative yield (reaction v).

Preparation of the segmental ligands HL5,6 is divided in fourth steps. Firstly, sequential Phillips coupling reactions (reactions vi/vii, Scheme 3) with successive introduction of different n class="Chemical">pyridine arms, (6), (7), and (9), are performed on the central dinitro, bis-(N-methylamino)diphenylmethane synthon (8). Secondly, the resulting bis-amides (11) and (14) are reduced (reactions viii, ix) in presence of a large excess of iron to form the bis(benzimidazole) intermediates (12) and (15). Finally, basic hydrolysis of both ethylester functions (reactions x) leads to the targeted segmental ligands with overall yields (steps iii-x in Schemes 2, 3) of 18.8 and 18.4% for HL5 and HL6, respectively.

Speciation in solution

Conditional stability constants of both homometallic (M = n class="Chemical">ZnII, LaIII, EuIII, LuIII) and heterometallic (M1 = ZnII, M2 = LaIII, EuIII, LuIII) complexes have been determined in Tris-HCl 0.1 M (pH 7.4) at 295 K by spectrophotometric titrations of the ligands (1.43 × 10−5 M for HL5 and 1.62 × 10−5 M for HL6, corresponding to an absorbance of about 0.5) with concentrated solutions of the metal perchlorates: 2.5–5.0 × 10−3 M for homometallic titrations and 2 × 10−4 M for each cation in the case of heterometallic titrations, in view of the poorer solubility of the hetero species. Titrations were performed batch wise for 20–25 [M]/[HL] (i = 5.6) ratios ranging between 0 and 2 (0 and 4 for EuIII + ZnII, respectively). The first attempts to determine the speciation of the complexes revealed unreliable due to the slow kinetic of formation. Therefore, the time required to reach equilibrium was determined by luminescence spectroscopy, monitoring both the ligand fluorescence (ZnII-HL6 and GdIII-HL6 systems) and the phosphorescence of the EuIII ion (EuIII-HL6 and EuIII-ZnII-HL6 systems). In the case of the lanthanide solutions with 1:3 and 2:3 Ln:HL6 ratios, steady states were reached within times not exceeding 1 h at room temperature. On the other hand, equilibrium times could be estimated at about 5–6 days at 313 K for heterometallic solutions. Consequently, solutions were carefully equilibrated before recording spectra, taking these data into consideration: 2 h at room temperature for homometallic solutions and 7 days at 313 K for heterometallic mixtures. These observations are interesting because in previous works, the kinetics of formation of homodinuclear 4f-4f helicates with a ligand similar to HLC1 but with carboxylic acid groups replaced with diethylamide groups (Hamacek et al., 2003) or with a bis(8-hydroxyquinolinate) ligand (Comby et al., 2009) was found to be fast in acetonitrile, equilibrium being reached within minutes. Similarly, [Eu2(LC1)3] forms within 10 min in water at pH 6.15 (Elhabiri et al., 2004). If the observed kinetics for the 1:3 and 2:3 Ln:HL6 complexes is not too different from the latter observation, formation of the ZnIIEuIII helicate is about two orders of magnitude slower.

In the case of ligand HL5, the spectra corresponding to the titration with lanthanum could be analyzed with a model including [La(L5)](3 − (n = 1, 2, 3) and [La2(L5)3]3+ species: the corresponding logβ1 and logβ23 being 8.4(3), 14.2(5), 20.4(4), and 29.2(6), pointing to the formation of a very stable helicate, despite the mismatch between the ligand denticity (3 + 2) and the coordination number requirements of LaIII. On the other hand, data with n class="Chemical">lutetium gave a less satisfying fit. Moreover, when the ligand was titrated with zinc ions or with an equimolar mixture of zinc and lanthanide ions partial precipitation occurred and the residual absorbance at the end of the titration was markedly smaller than at the beginning. For this reason, no further experiments have been conducted with HL5 and we have concentrated our efforts on ligand HL6.

For the titrations of HL6 with ZnII and EuIII, factor analysis pointed to the presence of 3–4 species in solution, including the free ligand. However, the fitting procedure was not straightforward and several models were tested. The best convergence and smallest residuals were obtained for the following sets of equilibria (charges are omitted for clarity):

Recalculated spectra are heavily correlated (Figures S1, S2, Supplementary Material), which explains the difficulties in the fitting procedure. The corresponding conditional stability constants are listed in Table 1. In the case of ZnII, the main species at 2:3 n class="Chemical">Zn:L stoichiometric ratio is the dinuclear complex (Figure 2, top) while the 1:3 complex remains a minor species (maximum speciation: 21% at R = 0.20); when R further increases, the 2:3 complex transforms into a 2:2 species. This behavior is in line with our previous results (Piguet and Bünzli, 2010). The tridentate-bidentate compartmental ligand HL6 is not well-suited for building triple-stranded helicates with LnIII ions (two tridentate coordination units would be required) and this is seen in the corresponding speciation diagram: the dominant species is a 1:3 complex, with a 75% speciation for R = 0.33 (Figure 2, middle). For this ratio, only a small quantity of the 2:3 species is present (8%). Absorbance values extracted at different wavelengths for the titrations with ZnII and EuIII (Figures S1, S2, Supplementary Material) are compatible with the initial formation of 1:3 species.

Table 1

Conditional stability constants in Tris-HCl (0.1 M, pH 7.4) and 295 K extracted from the spectrophotometric titrations of HL.

Metal ion(s)	Logβ13	Logβ22	Logβ23	Logβ113
ZnII	18.3 (4)	21.7 (4)	27.8 (4)	–
EuIII	17.5 (2)	–	22.8 (2)	–
ZnII + EuIII (1:1)	–	18.7 (3)	–	20.6 (3)

Standard deviations are given within parentheses.

Figure 2

Speciation diagrams calculated from the titration of HL Corresponding stability constants are listed in Table 1.

The titration with a mixture of metal ions has been conducted in a slightly different way, due to reduced solubility of the formed products, the concentration of each n class="Chemical">metal ion has been set to 2.00 × 10−4 M only. Again fit of the data was difficult in view of the correlated spectra (Figure S3, Supplementary Material), so that the extracted data and corresponding discussion have to be taken with care. Indeed, logβ22 for [Zn2(L6)2]2+ extracted from this titration amounts to 18.7(3) whereas a value of 21.7(4) was found from the homometallic titration. We think, however, that the salient features are correct: contrary to what was expected, and found for other ZnII-LnIII helicates in acetonitrile, for instance with L2 (Edder et al., 2000), the 1:1:3 species is not the dominant one, accounting for only 38% of the speciation at the 1:1:3 stoichiometric ratio. Another species is present in sizeable quantity (18%), namely the ZnII 2:2 complex which is less stable than the 1:1:3 species by less than two orders of magnitude. So it seems there is competition between ZnII and EuIII for the tridentate coordination unit of (L6)−. This competition is further demonstrated by an experiment in which ZnII was added to a 1:3 Eu:(L6)−stoichiometric solution 5.4 μM in EuIII up to an Eu:Zn ratio equal to 1. The EuIII luminescence intensity clearly decreases while ligand fluorescence centered at 450 nm increases (Figures S4, S5, Supplementary Material). Moreover, the ES-MS spectra discussed below point to other species being present in solution and the low solubility exhibited by this mixed system could well reflect the formation of polymeric (hydroxide?) species as well.

In order to substantiate the speciation determined by UV-visible titrations and, also, to determine if lighter and heavier lanthanides would lead to the same species in solution, ES-MS spectra of 1:1:3 n class="Chemical">Zn:Ln:(L6)− solutions in acetonitrile:water (1:1) containing 1% of formic acid and with total ligand concentration equal to 3 mM have been recorded for Ln = Nd and Yb. The main observed peaks are listed in Table 2. The findings indeed partly corroborate those from UV-visible titrations. For the Nd-containing sample, the [ZnNd(L6)3]2+ complex is detected as a quadruple charged (+2H+) species, along with [Nd(L6)3] and [Zn(L6)2], the latter giving rise to several solvated species and/or adducts with sodium and potassium. Spectra for the Yb-containing samples are simpler; here again, the 1:1:3 species is detected through a peak with a sizeable intensity the high-resolution scan of which matches well the calculated isotopic distribution (Figure 3). As for neodymium, an ytterbium 1:3 species is present, as well as the 1:2 zinc complex. In both cases, no 2:2 zinc complex was identified though, contrary to UV-visible titration data; we note, however that the solvent is different and that the conditions in the spectrometer may lead to dissociation of this species.

Table 2

Main peaks observed in the ESI-MS spectra of heterometallic solutions containing Zn.

Solution	Species	m/z (exp.)	Int.	Assignment	m/z (calcd)
Zn:Nd:(L6)−	[NdZn(L6)3]	808.53	20	[M + 2H]4+/4	808.53
1:1:3	[Nd(L6)3]	1594.58	6	[M + Na + H]2+/2	1594.59
		1604.57	5	[M + CH3CN + 2 H]2+/2	1604.61
	[Zn(L6)2]	1040.39	50	[M + 2 H]2+/2	1040.40
		1051.38	100	[M + Na + H]2+/2	1051.39
		1062.37	65	[M + CH3CN + 2 H]2+/2	1062.40
		701.25	65	[M + Na + 2 H]2+/3	701.26
		708.58	85	[M + 2 Na + H]3+/3	708.59
		713.90	85	[M + Na + K + H]3+/3	713.92
Zn:Yb:(L6)−	[YbZn(L6)3]	1087.73	25	[M + H]3+/3	1087.38
1:1:3	[Yb(L6)3]	1620.10	5	[M + 2 Na]2+/2	1620.10
	[Zn(L6)2]	1062.38	35	[M + 2 Na]2+/2	1062.38

Figure 3

Calculated (top) and experimental (bottom) isotopic distribution for {[ZnYb(L.

Photophysical properties of the solutions

Absorption spectra of ligand (L6)− and various solutions containing LnIII ions (Ln = Eu, Gd) or an equimolar EuIII/ZnII mixture are reported on Figure 4. The ligand absorption band at 319 nm can be assigned to a π→π* transition involving intramolecular electron transfer from the n class="Chemical">benzimidazole units to the pyridine and carboxylic groups. This band is red-shifted to 326.5–327 nm in the solutions containing LnIII ions only while the presence of ZnII results in a slightly larger shift, to 329.5 nm. The molar absorption coefficients of the 1:3 solutions are, within experimental errors, equal to three times the molar absorption coefficient of the free ligand, while they are marginally smaller (−3.5%) for the 2:3 and 1:1:3 solutions (Table 3).

Figure 4

Absorption spectra of ligand (L Total ligand concentration: 5.4 μM for the free ligand and 16.2 μM for the other solutions. The arrow indicates an artifact due to lamp switching.

Table 3

Photophysical data of the free and coordinated (L.

	(L6)−	Eu:(L6)−	Gd:(L6)−	Eu:(L6)−	Zn:Eu:(L6)−
		1:3	1:3	2:3	1:1:3
E(*π←π)a	31,450	30,630	30,580	30,630	30,350
Logε	4.50	4.97	4.98	4.96	4.96
E(1ππ*)b	21,450	22,350	22,350	22,450	21,950

From absorption spectra, maximum of band envelope.

From fluorescence spectra, maximum of band envelope.

Upon excitation into the 319-nm absorption band, ligand fluorescence emission is seen as a broad feature with maximum at 466 nm (Figure 5) and the corresponding excitation spectrum matches the absorption spectrum. At 77 K and upon enforcing a 50-μs delay time, weak phosphorescence is detected with a maximum at 506 nm. For the 1:3 EuIII solution, fluorescence of the ligand is still seen, representing 37% of the total emission of the sample; this is consistent with the fact that the solution contains about 17% of free ligand (Figure 2, middle). In addition characteristic f-f emission from the Eu(5D0) level is detected. A striking feature is that this spectrum is quite typical of a species with pseudo D3 symmetry and is quasi identical to the one recorded for the [Eu2(LC2)3] helicate (Chauvin et al., 2008). In particular, the branching ratios expressed with respect to the intensity of the magnetic dipole transition, I(5D0 → 7F)/I(5D0 → 7F1) are very similar for the two samples (data for [Eu2(LC2)3] are between parentheses): 0.02 (0.01), 1.00 (1.00), 0.87 (0.95), 0.16 (0.13), 1.62 (1.72), and 0.05 (n.a.). The splitting of the 5D0 → 7F1 transition is also very similar, 170 vs. 161 cm−1. These data point to luminescence arising from a coordination environment made up of 3 NNO moieties and very similar to the sites in [Eu2(LC2)3]; if some coordination were to occur through the bidentate site, then the coordination sphere would be completed by water molecules, leading to a poorly luminescent species. The solution also contains 8% of the 2:3 species, featuring two different metal ion sites (NNO)3 and (NN)3; the first one will give a spectrum identical to the one of the 1:3 complex, while the second will be poorly luminescent and therefore its contribution to the emission spectrum can be neglected. As an additional proof, the decay curve of the Eu(5D0) luminescence is perfectly monoexponential, with a lifetime of 2.7 ms (2.4 ms for [Eu2(LC2)3]), confirming that emission essentially originates from very similar coordination environments. Emission spectra of solutions with stoichiometric ratios Eu:(L6)− 2:3 and Zn:Eu:(L6)− 1:1:3 display spectra identical to the one of the 1:3 solution (Figure S6, Supplementary Material), consistent with the speciation reported in Figure 2; in particular, the emission intensity of the heterometallic solution is weak, due to the low concentration in 1:1:3 species (38%, which translates in 19% with respect to the europium site).

Figure 5

Left: Normalized absorption and excitation spectra of the free ligand (top) and the 1:3 solution containing Eu Spectra are for solutions in Tris-HCl 0.1 M (pH 7.4) at 295 K, except for the phosphorescence spectrum of (L6)− measured at 77 K with a 50-μs gate time.

Low-temperature emission spectra are presented on Figure 6 for the ligand, a GdIII-containing solution and the Eu:Zn 1:1 sample. Upon enforcing a 50-μs delay time, fluorescence of the ligand almost disappears to the benefit of a phosphorescence band centered at 509 nm. In the Gd:(L6)− 1:3 sample, this band is red shifted at 525 nm and presents a vibrational structure (463, 494, 525, 559 nm) with ≈1200 cm−1 spacing, typical of a ring breathing mode. The Eu:n class="Chemical">Zn sample also displays ligand fluorescence and phosphorescence, again consistent with the speciation of the solution. The ligand phosphorescence band for this sample is identical to the one exhibited by the Gd sample. From these spectra, the 0-phonon energy of the triplet state of the bound ligand can be estimated to be 21,600 cm−1, while the 0-phonon energy of the singlet state lies at about 26,000 cm−1, as estimated from the onset of the fluorescence band. These energies are close to those reported for (LC2)2− (Chauvin et al., 2008) and are adequate for ensuring efficient intersystem crossing and energy transfer onto the 5D1 (19,030 cm−1) and 5D0 (17,230 cm−1) levels of EuIII; on the other hand the quasi resonance between 3ππ* and 5D2 (21,500 cm−1) may generate some back energy transfer.

Figure 6

Emission spectra of frozen solutions in Tris-HCl 0.1 M (pH 7.4, 77 K) of the ligand, a Gd Black lines: spectra recorded without time delay; blue lines: 50 μ s time delay.

Lifetimes and quantum yields of the Eu(5D0) level are reported in Table 4. Despite the different speciation of the solutions, the luminescence decays can be fitted with monoexponential functions and the resulting lifetimes lie within a narrow range, 2.46–2.69 ms, the shortest figure corresponding to the solution with the largest concentration of the 2:3 (or 1:1:3) species, in line with the somewhat shorter lifetime reported for [Eu2(LCi)3], 2.43 ms for i = 1 (Elhabiri et al., 1999) and 2 (Chauvin et al., 2008) under similar experimental conditions. At low temperature, the lifetimes are much longer, pointing to temperature-dependent quenching mechanism(s) operating, e.g., back transfer (see above) or photo-induced electron transfer (PET). The radiative lifetimes can be estimated from the following equation: where AMD, 0 = 14.65 s−1 is the decay rate of the magnetic dipole 5D0 → 7F1 transition, n is the refractive index of the medium, and IMD and Itot are the integrated emission areas of the 5D0 → 7F1 and 5D0 → 7F (J = 0–6) transitions. The corresponding data lead to evaluation of the intrinsic quantum yield, i.e., the quantum yield upon direct excitation onto the 5D0 level, since it is very difficult to determine experimentally in view of the faint molar absorption coefficients of the f-f transitions. The sensitization efficiency of the ligand can subsequently be calculated:

Table 4

Observed and radiative lifetimes (τ), intrinsic and absolute quantum yields (.

Solution	Speciationa	τobs/ms	τrad/msb	QEuEu/%	QLEu/%	ηsens/%
Eu:(L6)− 1:3	1:3 75%,	2.69 ± 0.02	7.5 ± 0.7	36 ± 4	8 ± 1	22 ± 4
	2:3 8%	3.56 ± 0.04c
Eu:(L6)− 2:3	1:3 53%,	2.46 ± 0.06	7.7 ± 0.8	32 ± 4	8 ± 1	25 ± 5
	2:3 39%
Zn:Eu:(L6)− 1:1:3	1:1:3 38%	2.54 ± 0.15	7.5 ± 0.7	34 ± 4	5 ± 1	15 ± 3
		3.15 ± 0.09c

From Figure .

Calculated with eq. (6).

In frozen solution at 77 K.

Both sets of data, radiative lifetimes and intrinsic quantum yields, are consistent for the three samples and, moreover they compare very well with data reported for the [Eu2(LC1, 2)3] helicates: τrad = 6.8−6.9 ± 0.3 ms and QEuEu = 36–37 ± 4% (Bünzli et al., 2008). On the other hand, absolute quantum yields and sensitization efficiencies are about three-fold smaller compared to the reference helicates (QEu = 21–24%, ηsens = 58–67%) due to the non-quantitative formation of the species. It is however noteworthy that the quantum yields of the two solutions containing EuIII only, which feature approximately the same concentration of EuN6O3 sites (79 and 73% for 1:2 and 2:3 stoichiometric ratios, respectively), are equal, within experimental errors. For the heteron class="Chemical">metallic solution, the quantum yield is smaller, due to the small concentration of the 1:1:3 species, which, in addition features only one EuN6O3 coordination site.

Conclusion

Reaction of ligands HL5 and HL6 (Scheme 3) under physiological conditions with equimolar quantities of n class="Chemical">ZnII and LnIII ions did not lead to a thermodynamically controlled assembly of the desired 3d-4f helicates, as expected from work with HL4, the 1:1:3 complex representing only 40% of the speciation. This can be traced back to stability of the ZnII complexes with these ligands, even with respect to coordination to the tridentate unit, which is close to that of the LnIII complexes. Attempts to isolate solid state samples of the helicates with transition metal ions such as ZnII, CrIII, RuII also afforded mixtures which we did not succeed to purify to an acceptable level. There is no doubt that the NNO moiety of the ligand should be remodeled to get better recognition of the LnIII ions. An encouraging aspect, however, is that all luminescent data gathered for EuIII solutions with different compositions point to the formation of either 1:3 or 2:3, or 1:1:3 complexes in which the lanthanide ion is coordinated to the tridentate chelating unit of ligand HL6, a judged by the crystal field splitting and other photophysical parameters which reflect the peculiar signature of the Eu(NNO)3 environment. In particular, the radiative lifetimes and intrinsic quantum yields match those of the previously reported helicates [Eu2(LC1)3] and [Eu2(LC2)3] with bis(tridentate) ligands.

On the other hand, the synthetic strategy applied for the preparation of tridentate-bidentate compartmental ligands aimed at assembling 3d-4f binuclear complexes proved to be valuable in that the ligands are obtained in reasonable yields given the number of steps needed. Moreover, the strategy can be adapted to graft other substituents on the sulfonate groups through modification of the key building block 6 (Scheme 2), so that this class of ligands represent a valuable addition to the chemistry of 3d-4f complexes.

Materials and methods

Synthesis of the ligands

Sulfonation of 2-picoline (Delarge, 1965) and bromination of n class="Chemical">TEGOMe (Deiters et al., 2009) have been previously reported so that these steps are not described here, except for NMR and ESI-MS characterization of (3). Substituted pyridines (7) and (9) (Li et al., 2008; Deiters et al., 2009) and bis-(N-methylamino)diphenylmethane (8) (Piguet et al., 1992) were prepared according to literature procedures.

Starting materials and general procedures

Chemicals and solvents were purchased from Fluka A.G or Aldrich. Solvents were purified by passing them through activated alumina columns from In class="Chemical">nnovative Technology Inc. (Pangborn et al., 1996). Complexes were studied in solution only. Stock solutions of lanthanides were prepared just before use in freshly boiled, doubly distilled water from the corresponding Ln(ClO4)3·xH2O salts (Ln = La, Eu, Gd, Lu; x = 2.5–4.5). These salts were prepared from their oxides (Rhône-Poulenc, 99.99% and Catalysis or Research Chemicals, Phoenix, AZ) in the usual way (Bünzli and Mabillard, 1986). The concentrations of the solutions were determined by complexometric titrations using a standardized Na2H2EDTA in urotropine buffered medium and with xylenol orange as indicator (Schwarzenbach, 1957).

N-benzyl-2-[2-(2-methoxyethoxy)ethoxy]-N-{2-[2-(2-methoxyethoxy)ethoxy]ethyl}-ethanamine (1)

Benzylamine (2.5 g, 23.3 mmol), 1-bromo-2-[2-(2-methoxyethoxy)ethoxy]-ethane (11.59 g, 51.3 mmol) and n class="Chemical">Na2CO3 (5.44 g, 51.3 mmol) were heated and stirred in anhydrous CH3CN (30 mL) under inert atmosphere at 62°C for 76 h. After cooling, the reaction mixture was filtered and the white precipitate of Na2CO3 was washed with Et2O (about 50 mL). The resultant solution was evaporated under reduced pressure. The residue so obtained was re-dissolved in a hydrochloric acid solution (50 mL, 2 M) and extracted with Et2O (250 mL). The pH of the aqueous phase was then increased by addition of NaHCO3 up to saturation and the resulting solution was extracted with Et2O (3 × 250 mL). The three organic phases were combined, dried over Na2SO4, filtered, and concentrated under reduced pressure. The crude material was purified by column chromatography (silica gel, CH2Cl2/MeOH 100:0 → 97:3) to give pale yellow oil (6.32 g, 68% yield). 1H NMR (400 MHz, 298 K, CD3CN) δ (ppm): 2.66 (t, 3J = 6.2 Hz, 4H, NCH2CH2), 3.28 (s, 6H, OCH3), 3.44 (m, 4H, OCH2), 3.48–3.54 (m, 16H, OCH2), 3.67 (s, 2H, CH2), 7.24 (m. 1H, HPh.), 7.30 (m, 2H, HPh.), 7.33 (m, 2H, HPh.). 13C NMR (800 MHz, 298 K, CDCl3) δ (ppm): 53.86 (NCH2CH2O), 59.20 (OCH3), 59.86 (CH2), 70.00 (OCH2), 70.49 (OCH2), 70.68 (OCH2), 70.78 (OCH2), 72.06 (OCH2), 126.96 (CHPh.), 128.27 (CHPh.), 128.97 (CHPh), 139.85 (CPh. quat.). ESI-MS m/z calcd for [M + H+] (found): 400.27 (400.04).

2-[2-(2-methoxyethoxy)ethoxy]-N-{2-[2-(2-methoxyethoxy)ethoxy]ethyl}ethanamine (2)

Continuous flow hydrogenation of an n class="Chemical">ethanolic solution (0.05 M, 250 mL) of (1) (5.00 g, 12.5 mmol) was conducted with a safety H-Cube device from Thales Nanotechnology equipped with a HPLC pump under the following conditions; flow rate: 1 mL/min, catalyst cartridge: Pd/C; H2 pressure: 70 bar; temperature: 45°C. Ethanol and generated toluene were removed under reduced pressure and (2) obtained as a yellow oil was subsequently dried under vacuum (3.87 g, 100% yield). Note: one run was enough to fully convert (1) into (2) under the conditions mentioned above. 1H NMR (400 MHz, 298 K, CD3CN) δ (ppm): 2.73 (t, 3J = 6.2 Hz, 4H, NCH2CH2), 3.30 (s, 6H, OCH3), 3.46–3.57 (m, 20H, OCH2). 13C NMR (800 MHz, 298 K, CDCl3) δ (ppm): 49.30 (NCH2CH2), 59.21 (OCH3), 70.47 (OCH2), 70.63 (OCH2), 70.65 (OCH2), 70.67 (OCH2), 72.05 (OCH2). ESI-MS m/z calcd for [M + H+] (found): 310.23 (309.94).

6-methylpyridinium-3-sulfonate (3)

This compound was synthetized according to a procedure described in the literature (Delarge, 1965); NMR and ESI-MS data are however reported here for the first time. n class="Chemical">1H NMR (400 MHz, 298 K, D2O) δ (ppm): 2.81 (s, 3H, CH3), 7.97 (d, 3J = 8.5 Hz, 1H, HPy.), 8.69 (d, 3J = 8.5 Hz, 1H, HPy.), 8.97 (s, 1H, HPy.) 13C NMR (800 MHz, 298 K, D2O) δ (ppm): 19.15 (CH3), 128.55 (CHPy.), 138.35 (CHPy.), 140.16 (CPy. quat.), 142.95 (CHPy.), 156.86 (CPy. quat.). ESI-MS m/z calcd for [M+H+] (found): 174.02 (173.91); calcd for [M + CH3CN + H+] (found): 215.05 (214.87).

6-methylpyridinium-3-sulfonyl chloride (4)

Synthon (3) (1.00 g, 5.78 mmol) and n class="Chemical">PCl5 (1.91 g, 9.25 mmol) were suspended in POCl3 (5 mL) and stirred at room temperature for 48 h. Then, POCl3 was rotor-evaporated and the residue was dissolved in CH2Cl2 (25 mL). Crushed ice (about 5 g) was slowly added to this solution (beware, the reaction is highly exothermic!) and the resulting phases were separated. The aqueous phase was extracted with CH2Cl2 (3 × 50 mL). The combined organic phases were combined, washed with dilute NaHCO3 solution, dried over Na2SO4, filtered and concentrated under reduced pressure. The crude material was charged and eluted on a chromatography column (silica gel, Et2O/petroleum ether 50:50 → 90:10) to give a white solid (0.766 g, 70% yield). 1H NMR (400 MHz, 298 K, CDCl3) δ (ppm): 2.73 (s, 3H, CH3), 7.42 (d, 3J = 8.5 Hz, 1H, HPy.), 8.18 (dd, 3J = 8.5 Hz, 4J = 2.3 Hz, 1H, HPy.), 9.12 (d, 4J = 2.3 Hz, 1H, HPy.) 13C NMR (800 MHz, 298 K, DMSO-d6) δ (ppm): 19.36 (CH3), 127.68 (CHPy.), 138.23 (CHPy.), 142.49 (CHPy.), 144.30 (CPy. quat.), 154.30 (CPy. quat.). ESI-MS m/z calcd for [M + H+] (found): 191.99 (191.81).

N,N-bis{2-[2-(2-methoxyethoxy)ethoxy]ethyl}-6-methylpyridine-3-sulfonamide (5)

Compound (4) (0.900 g, 4.71 mmol) was dissolved in dry CH2Cl2 (about 20 mL) under n class="Chemical">N2 steam and 3.3 mL NEt3 (23.6 mmol) was added. The resulting solution was refluxed and a solution of CH2Cl2 containing (2) (1.75 g, 5.66 mmol) was added dropwise. The reflux was subsequently maintained for 16 h. After cooling, the solvent and excess of NEt3 were rotor-evaporated under reduced pressure. The residue was dissolved in CH2Cl2 (50 mL) and a saturated aqueous solution of NH4Cl (50 mL) was added. After separation, the aqueous phase was extracted with 3 × 50 mL CH2Cl2. The combined organic phases were reduced to a volume of about 100 mL. This solution was dried over Na2SO4, filtered, and evaporated under reduced pressure. The crude material was purified by column chromatography (silica gel, CH2Cl2/MeOH 100:0 → 97:3) to afford amber oil (1.81 g, 83% yield). 1H NMR (400 MHz, 298 K, CD3CN) δ (ppm): 2.58 (s, 3H, CH3), 3.28 (s, 6H, OCH3), 3.40 (m, 4H, OCH2CH2), 3.44–3.57 (m, 20H, OCH2), 7.37 (d, 3J = 8.2 Hz, 1H, HPy.), 8.03 (dd, 3J = 8.2 Hz, 4J = 2.4 Hz, 1H, HPy.), 8.86 (d, 4J = 2.4 Hz, 1H, HPy.) 13C NMR (800 MHz, 298 K, CDCl3) δ (ppm): 24.79 (CH3), 48.46 (NCH2CH2), 59.20 (OCH3), 69.90 (OCH2), 70.49 (OCH2), 70.62 (OCH2), 70.67 (OCH2), 72.04 (OCH2), 123.35 (CHPy.), 134.04 (CPy. quat.), 135.33 (CHPy.), 147.71 (CHPy.), 162.94 (CPy. quat.). ESI-MS m/z calcd for [M + H+] (found): 465.23 (465.00); calcd for [M + Na+] (found): 487.01 (487.21).

5-(bis{2-[2-(2-methoxyethoxy)ethoxy]ethyl}sulfamoyl)pyridine-2-carboxylic acid (6)

Compound (5) (1.80 g, 3.88 mmol) was added to a suspension of SeO2 (1.94 g, 17.45 mmol) in dry n class="Chemical">pyridine (60 mL) maintained under an N2 stream. The heterogeneous mixture was refluxed for 24 h and filtered through Celite® after cooling. Celite® was further washed with Et2O (about 100 mL) and the solvents were removed under reduced pressure. The residue was dissolved in distilled H2O (about 20 mL) and the pH was increased to 10 by addition of aqueous NaOH (5%). The aqueous phase was then extracted with CH2Cl2 (3 × 100 mL). The aqueous phase was acidified to pH 3 by adding aqueous hydrochloric acid (25%) and the resulting solution was extracted again with CH2Cl2 (3 × 100 mL). The organic phases were combined, reduced to a volume of about 100 mL, dried over Na2SO4, filtered, and rotor-evaporated under reduced pressure. After drying, (6) was obtained as an amber oil (1.83 g, 96% yield). 1H NMR (400 MHz, 298 K, acetone-d6) δ (ppm): 3.29 (s, 6H, OCH3), 3.45–3.49 (m, 12H, OCH2), 3.54 (m, 4H, OCH2), 3.58 (m, 4H, OCH2), 3.64 (m, 4H, OCH2), 8.32 (d, 3J = 8.1 Hz, 1H, HPy.), 8.50 (dd, 3J = 8.1 Hz, 4J = 2.2 Hz, 1H, HPy.), 9.09 (d, 4J = 2.2 Hz, 1H, HPy.) 13C NMR (800 MHz, 298 K, CDCl3) δ (ppm): 47.71 (NCH2CH2), 59.16 (OCH3), 67.21 (OCH2), 69.37 (OCH2), 70.46 (OCH2), 70.57 (OCH2), 72.06 (OCH2), 123.97 (CHPy.), 137.71 (CHPy.), 141.33 (CHPy.), 147.19 (CHPy.), 148.35 (CPy. quat.), 163.18 (COOH). ESI-MS m/z calcd for [M + H+] (found): 495.20 (495.00).

Ethyl 6-(methyl{4-[4-(methylamino)-3-nitrobenzyl]-2-nitrophenyl}carbamoyl)pyridine-2-carboxylate (10)

A mixture of 2,6-pyridinecarboxylic acid monoethyl ester (7) (1.00 g, 5.13 mmol), freshly distilled n class="Chemical">SOCl2 (6.10 g, 51.3 mmol), and dry DMF (200 μ L, 2.56 mmol) were refluxed in dry CH2Cl2 (50 mL) under an inert atmosphere for 2 h. After evaporation and pumping for 2 h, the pale yellow solid formed was re-dissolved in dry CH2Cl2 (50 mL). 3,3′-dinitro-4,4′-bis(N-methylamino)diphenylmethane (8) (1.46 g, 4.61 mmol) and NEt3 (2.00 mL) were added to this solution. The resulting mixture was refluxed for 16 h and evaporated. The red-brown residue was re-dissolved in CH2Cl2 (100 mL) and washed with half-saturated NH4Cl solution (100 mL). After separation, the aqueous phase was extracted with CH2CL2 (2 × 100 mL). The combined organic phases were dried over Na2SO4 and evaporated. The resulting red-brown solid was purified by column chromatography (silica gel, CH2Cl2/hexane 95:5 → CH2Cl2/MeOH 99:1) to give the mono-substituted product (10) as orange solid (1.09 g, 48% yield). 1H NMR (400 MHz, 433 K, DMSO-d6) δ (ppm): 1.30 (t, 3J = 7.2 Hz, 3H, OCH2CH3), 3.00 (d, 3J = 5.1 Hz, 3H, NHCH3), 3.41 (s, 3H, NCH3), 4.00 (s, 2H, CH2), 4.25 (q,3J = 7.2 Hz, 2H, OCH2CH3), 6.95 (d, 3J = 8.7 Hz, 1H, HBenz.), 7.36 (d, 3J = 8.7 Hz, 1H, HBenz.), 7.44 (d,3J = 7.8 Hz, 1H, HBenz.), 7.51 (d, 3J = 7.8 Hz, 1H, HBenz.), 7.69 (s (broad), 1H, NH), 7.83 (s, 1H, HBenz.), 7.84 (d, 3J = 8.8 Hz, 1H, HPy.), 7.89 (d, 3J = 9.2 Hz, 1H, HPy.), 7.91 (s, 1H, HBenz.), 7.98 (dd, 3J = 9.2 Hz, 3J = 8.8 Hz, 1H, HPy.). 13C NMR (800 MHz, 327 K, DMSO-d6) δ (ppm): 13.66 (OCH2CH3), 29.43 (NHCH3), 37.47 (NCH3), 37.92 (CH2), 60.73 (OCH2CH3), 114.44 (CHBenz.), 124.85 (CHBenz.), 125.16 (CHBenz.), 125.21 (CHPy.), 126.34 (CHPy.), 126.75 (CHPy.), 130.59 (CBenz. quat.), 131.10 CBenz. quat.), 134.45 (CHBenz.), 135.84 (CBenz. quat.), 137.02 (CHBenz.), 138.32 (CHPy.), 141.95 (CBenz. quat.), 144.60 (CBenz. quat.), 145.03 (CBenz. quat.), 145.62 (CPy. quat.), 151.96 (CPy. quat.), 163.57 (CONMe), 165.49 (COOEt). ESI-MS m/z calcd for [M + H+] (found): 494.17 (493.97); calcd for [M + Na+] (found): 516.14 (515.96).

Note: The n class="Chemical">mono- (10, 13) and bis- (11, 14) amide intermediates display at least two different conformations at 298 K with enough slow exchange rates to be observed on both 1H and 13C NMR spectra. Thus, the NMR spectra of these compounds were recorded at higher temperature to give one set of averaged signals.

Ethyl 6-[(4-{4-[{[5-(bis{2-[2-(2-methoxyethoxy)ethoxy]ethyl}sulfamoyl)pyridin-2-yl]-carbonyl}(methyl)amino]-3-nitrobenzyl}-2-nitrophenyl)(methyl)carbamoyl]pyridine-2-carboxylate (11)

A mixture of (6) (700 mg, 1.42 mmol), freshly distilled SOCl2 (3.37 g, 28.3 mmol), and n class="Disease">dry DMF (55 μL, 0.708 mmol) were refluxed in dry CH2Cl2 (50 mL) under an inert atmosphere for 2 h. After evaporation and pumping for 2 h, the brown oil formed was re-dissolved in dry CH2Cl2 (25 mL) and NEt3 (2.00 mL) was added. This mixture was refluxed and a solution of dry CH2Cl2 (25 mL) containing (10) (437 mg, 8.85 mmol) was added drop-wise over a period of 30 min. The resulting solution was kept under reflux for 16 h. and evaporated. The brown residue was re-dissolved in CH2Cl2 (100 mL) and washed with half-saturated NH4Cl solution (100 mL). After separation, the aqueous phase was extracted with CH2Cl2 (2 × 100 mL). The combined organic phases were dried over Na2SO4 and evaporated. The crude material was purified by column chromatography (silica gel, CH2Cl2/MeOH 99:1 → CH2Cl2/MeOH 95:5) to afford brown oil (840 mg, 98% yield). 1H NMR (400 MHz, 433 K, DMSO-d6) δ (ppm): 1.29 (t, 3J = 7.2 Hz, 3H, OCH2CH3), 3.28 (s, 6H, OCH3), 3.40 (s, 3H, NCH3), 3.41 (s, 3H, NCH3), 3.41 (m, 4H, NCH2CH2), 3.46–3.61 (m, 20H, OCH2), 4.16 (s (broad), 2H, CH2), 4.25 (q, 3J = 7.2 Hz, 2H, OCH2CH3), 7.48 (d, 3J = 8.9 Hz, 2H, HBenz.), 7.49 (d,3J = 8.9 Hz, 2H, HBenz.), 7.80 (dd, 3J = 8.5 Hz, 4J = 1.0 Hz, 1H, HPy.), 7.85 (dd, 3J = 7.9 Hz, 4J = 1.0 Hz, 1H, HPy.), 7.86 (s, 1H, HBenz.), 7.89 (d, 3J = 9.2 Hz, 1H, HPy.), 7.90 (s, 1H, HBenz.), 7.99 (dd, 3J = 8.5 Hz, 3J = 7.9 Hz, 1H, HPy.), 8.23 (d, 3J = 9.2 Hz, 1H, HPy.), 8.63 (s, 1H, HPy.). 13C NMR (800 MHz, 327 K, DMSO-d6) δ (ppm): 13.69 (OCH2CH3), 37.45 (NCH3), 38.25 (NCH3), 47.24 (NCH2CH2), 47.37 (CH2), 57.82 (OCH3), 60.75 (OCH2CH3), 68.33 (OCH2), 68.48 (OCH2), 69.39 (OCH2), 69.42 (OCH2), 71.09 (OCH2), 123.89 (CHBenz.), 124.75 (CHBenz.), 124.82 (CHBenz.), 125.15 (CHPy.), 126.80 (CHPy.), 131.21 (CHBenz.), 134.39 (CHBenz.), 134.54 (CHBenz.), 135.21 (CBenz. quat.), 135.77 (CHPy.), 135.87 (CHPy.), 136.19 (CBenz. quat.), 136.68 (CHPy.), 138.36 (CHPy.), 140.55 (CBenz. quat.), 141.37 (CBenz. quat.), 145.02 (CBenz. quat.), 145.61 (CPy. quat.), 145.77 (CBenz. quat.), 147.13 (CPy. quat.), 151.86 (CPy. quat.), 155.07 (CPy. quat.), 163.61 (CONMe.), 165.25 (CONMe), 165.42 (COOEt). ESI-MS m/z calcd for [M + H+] (found): 970.36 (970.20); calcd for [M + Na+] (found): 992.34 (992.17).

Ethyl 6-[5-({2-[5-(bis{2-[2-(2-methoxyethoxy)ethoxy]ethyl}sulfamoyl)pyridin-2-yl]-1-methyl-1H-benzimidazol-5-yl}methyl)-1-methyl-1H-benzimidazol-2-yl]pyridine-2-carboxylate (12)

Freshly activated iron powder (1.41 g, 25.3 mmol) and n class="Chemical">HCl solution (1.75 mL, 25%) were added to an EtOH/H2O solution (165/41 mL) containing (11) (816 mg, 0.842 mmol). The mixture was refluxed under an inert atmosphere for 16 h. The solution was cooled, the excess of un-reacted iron filtered, and evaporated. The crude product was re-dissolved in absolute EtOH (30 mL). An H2SO4 solution (2 mL, 97%) was carefully added and the solution was refluxed overnight. It was cooled and the solvents were rotor-evaporated. Distilled water (100 mL) was added and the pH was adjusted to 6 with an aqueous saturated solution of NaHCO3. Na2EDTA (6.27 g, 16.8 mmol) was added to this solution followed by addition of H2O2 (1.5 mL, 30%) which resulted in the solution turning brown. The pH was then increased to 7 with an aqueous saturated solution of NaHCO3 before extraction with CH2Cl2 (5 × 100 mL). The organic phases were combined, dried over Na2SO4, filtered, and evaporated to dryness, resulting in a brown crude solid which was purified by column chromatography (silica gel; CH2Cl2 → CH2Cl2/MeOH 96:4) to give a pale yellow solid (532 mg, 79% yield). 1H NMR (400 MHz, 298 K, acetone-d6) δ (ppm): 1.43 (t, 3J = 6.8 Hz, 3H, OCH2CH3), 3.25 (s, 6H, OCH3), 3.44 (m, 4H, NCH2CH2), 3.50–3.54 (m, 12H, OCH2), 3.59 (m, 4H, OCH2), 3.66 (m, 4H, OCH2), 4.29 (s (broad), 2H, CH2), 4.35 (s, 3H, NCH3), 4.43 (s, 3H, NCH3), 4.44 (q, 3J = 6.8 Hz, 2H, OCH2CH3), 7.32 (dd, 3J = 8.5 Hz, 4J = 1.3 Hz, 1H, HBenz.), 7.34 (dd, 3J = 8.5 Hz, 4J = 1.3 Hz, 1H, HBenz.), 7.53 (d, 3J = 8.5 Hz, 1H, HBenz.), 7.55 (d, 3J = 8.5 Hz, 1H, HBenz.), 7.66 (d, 4J = 1.3 Hz, 1H, HBenz.), 7.68 (d, 4J = 1.3 Hz, 1H, HBenz.), 8.15 (d, 3J = 4.4 Hz, 2H, HPy.), 8.42 (dd, 3J = 8.5 Hz, 4J = 2.4 Hz, 1H, HPy.), 8.59 (d, 3J = 8.5 Hz, 1H, HPy.), 8.62 (t, 3J = 4.4 Hz, 1H, HPy.), 9.12 (d, 4J = 2.4 Hz, 1H, HPy.). 13C NMR (800 MHz, 298 K, CDCl3) δ (ppm): 14.44 (OCH2CH3), 33.11 (NCH3), 33.27 (NCH3), 42.34 (CH2), 48.37 (NCH2CH2), 59.18 (OCH3), 62.01 (OCH2CH3), 69.79 (OCH2), 70.51 (OCH2), 70.62 (OCH2), 70.65 (OCH2), 72.01 (OCH2), 110.19 (CHBenz.), 110.25 (CHBenz.), 120.07 (CHBenz.), 120.28 (CHBenz.), 124.35 (CHBenz.), 124.87 (CHPy.), 125.32 (CHPy.), 125.85 (CHPy.), 127.48 (CHPy.), 135.61 (CHPy.), 136.09 (CBenz. quat.), 136.25 (CBenz. quat.), 136.61 (CBenz. quat.), 137.04 (CBenz. quat.), 138.00 (CHPy.), 143.00 (CBenz. quat.), 147.17 (CPy. quat.), 147.21 (CPy. quat.), 148.63 (CPy. quat.), 149.27 (CBenz. quat.), 150.80 (CPy.quat.), 153.71 (CBenz. quat.), 165.08 (COOEt). ESI-MS m/z calcd for [M + H+] (found): 874.38 (874.37); calcd for [M + 2H+]/2 (found): 437.83 (437.69).

6-[5-({2-[5-(bis{2-[2-(2-methoxyethoxy)ethoxy]ethyl}sulfamoyl)pyridin-2-yl]-1-methyl-1H-benzimidazol-5-yl}methyl)-1-methyl-1H-benzimidazol-2-yl]pyridine-2-carboxylic acid (HL4)

Intermediate (12) (525 mg, 0.602 mmol) was dissolved in an absolute EtOH/n class="Chemical">H2O mixture (20:20 mL) containing NaOH (28.9 mg, 0.721 mmol). The mixture was stirred at 60°C for 16 h. After completion of the reaction, the solvents were evaporated. The residue was dissolved in distilled water (50 mL) and the resulting aqueous solution was acidified to pH = 2 by addition of 0.02 M hydrochloric acid. The acidic solution was then extracted with CH2Cl2 (5 × 100 mL), dried over Na2SO4 and evaporated. The crude product was triturated with hexane (100 mL), filtered, and dried under vacuum to give a pale yellow solid (498 mg, 98% yield). 1H NMR (400 MHz, 298 K, acetone-d6) δ (ppm): 3.25 (s, 6H, OCH3), 3.43 (m, 4H, NCH2CH2), 3.50–3.54 (m, 12H, OCH2), 3.59 (m, 4H, OCH2), 3.66 (m, 4H, OCH2), 4.30 (s (broad), 2H, CH2), 4.35 (s, 3H, NCH3), 4.38 (s, 3H, NCH3), 7.32 (d, 3J = 8.1 Hz, 1H, HBenz.), 7.34 (d, 3J = 8.5 Hz, 1H, HBenz.), 7.55 (d, 3J = 8.1 Hz, HBenz.), 7.55 (d, 3J = 8.5 Hz, 1H, HBenz.), 7.68 (s, 1H, HBenz.), 7.68 (s, 1H, HBenz.), 8.20 (d,3J = 6.4 Hz, 1H, HPy.), 8.21 (d, 3J = 4.7 Hz, 1H, HPy.), 8.41 (dd,3J = 8.5 Hz, 4J = 0.6 Hz, 1H, HPy.), 8.60 (d,3J = 8.5 Hz, 1H, HPy.), 8.60 (dd,3J = 6.4 Hz, 3J = 4.7 Hz, 1H, HPy.), 9.12 (d,4J = 0.6 Hz, 1H, HPy.). 13C NMR (800 MHz, 298 K, CDCl3) δ (ppm): 32.62 (NCH3), 33.31 (NCH3), 42.30 (CH2), 48.38 (NCH2CH2), 59.18 (OCH3), 69.79 (OCH2), 70.50 (OCH2), 70.62 (OCH2), 70.64 (OCH2), 72.01 (OCH2), 110.34 (CHBenz.), 120.01 (CHBenz.), 120.17 (CHBenz.), 124.36 (CHBenz.), 124.42 (CHBenz.), 125.82 (CHPy.), 125.86 (CHPy.), 128.64 (CHPy.), 135.51 (CBenz. quat.), 135.69 (CHPy.), 136.20 (CPy. quat.), 136.95 (CBenz. quat.), 137.31 (CBenz. quat.), 139.24 (CHPy.), 142.29 (CBenz. quat.), 142.82 (CBenz. quat.), 146.34 (CPy. quat.), 147.20 (CHPy.), 148.66 (CPy. quat.), 148.71 (CPy. quat.), 149.11 (CBenz. quat.), 153.47 (CBenz. quat.), 164.72 (COOH). ESI-MS m/z calc for [M + H+] (found): 846.35 (846.21); calcd for [M+2H+]/2 (found): 423.68 (423.75). Anal. Calcd for C42H51N7O10S·H2O (found): C, 58.43 (58.24); H, 6.18 (6.23); N, 11.36 (11.07).

Ethyl 4-{2-[2-(2-methoxyethoxy)ethoxy]ethoxy}-6-(methyl{4-[4-(methylamino)-3-nitrobenzyl]-2-nitrophenyl}carbamoyl)pyridine-2-carboxylate (13)

A mixture of 6-(ethoxycarbonyl)-4-{2-[2-(2-methoxyethoxy)ethoxy]ethoxy]n class="Chemical">pyridine-2-carboxylic acid (9) (0.718 g, 2.01 mmol), freshly distilled SOCl2 (2.39 g, 20.0 mmol), and dry DMF (77 μ L, 1.05 mmol) were refluxed in dry CH2Cl2 (25 mL) under an inert atmosphere for 2 h. After evaporation and pumping for 2 h, the pale yellow oil formed was re-dissolved in dry CH2Cl2 (25 mL). 3,3′-dinitro-4,4′-bis(N-methylamino)diphenylmethane (8) (635 mg, 2.01 mmol) andNEt3 (1.50 mL) were then added. The resulting mixture was refluxed for 16 h. and evaporated. The red-brown residue was re-dissolved in CH2Cl2 (100 mL) and washed with half-saturated NH4Cl solution (100 mL). After separation, the aqueous phase was extracted with CH2Cl2 (2 × 100 mL). The combined organic phases were dried over Na2SO4 and evaporated. The resulting red-brown solid was purified by column chromatography (silica gel, CH2Cl2 → CH2Cl2/MeOH 97:3) to give the mono-substituted product (13) as orange-red oil (0.614 g, 47% yield). 1H NMR (400 MHz, 433 K, DMSO-d6) δ (ppm): 1.27 (t, 3J = 7.2 Hz, 3H, OCH2CH3), 2.99 (d, 3J = 2.7 Hz, 3H, NHCH3), 3.27 (s, 3H, OCH3), 3.38 (s, 3H, NCH3), 3.45 (m, 2H, OCH2), 3.54–3.57 (m, 4H, OCH2), 3.60 (m, 2H, OCH2), 3.79 (m, 2H, OCH2), 3.99 (s, 2H, CH2), 4.21 (q, 3J = 7.2 Hz, 2H, OCH2CH3), 4.28 (m, 2H, OCH2), 6.95 (d, 3J = 8.9 Hz, 1H, HBenz.), 7.36 (d,4J = 1.0 Hz, 1H, HPy.), 7.37 (d, 3J = 8.9 Hz, 1H, HBenz.), 7.42 (d,4J = 1.0 Hz, 1H, HPy.), 7.43 (d,3J = 7.8 Hz, 1H, HBenz.), 7.51 (d, 3J = 7.8 Hz, 1H, HBenz.), 7.77 (s (broad), 1H, NH), 7.85 (s, 1H, HBenz.), 7.92 (s, 1H, HBenz.). 13C NMR (800 MHz, 327 K, DMSO-d6) δ (ppm): 13.33 (OCH2CH3), 30.13 (NHCH3), 38.17 (NCH3), 38.63 (CH2), 58.50 (OCH3), 61.47 (OCH2CH3), 68.70 (OCH2), 68.94 (OCH2), 70.11 (OCH2), 70.30 (OCH2), 70.52 (OCH2), 71.79 (OCH2), 112.53 (CHPy.), 113.40 (CHPy.), 115.15 (CHBenz.), 125.54 (CHBenz.), 125.91 (CHBenz.), 127.05 (CHBenz.), 131.28 (CBenz. quat.), 131.71 CBenz. quat.), 135.10 (CHBenz.), 136.53 (CBenz. quat.), 137.73 (CHBenz.), 142.65 (CBenz. quat.), 145.30 (CBenz. quat.), 145.79 (CBenz. quat.), 148.32 (CPy. quat.), 154.47 (CPy. quat.), 164.24 (CONMe), 166.07 (COOEt), 166.43 (CPy.−O quat.). ESI-MS m/z calcd for [M + H+] (found): 656.26 (656.06).

Ethyl 6-[(4-{4-[{[5-(bis{2-[2-(2-methoxyethoxy)ethoxy]ethyl}sulfamoyl)pyridin-2-yl]-carbonyl}(methyl)amino]-3-nitrobenzyl}-2-nitrophenyl)(methyl)carbamoyl]-4-{2-[2-(2-methoxyethoxy)ethoxy]ethoxy}pyridine-2-carboxylate (14)

A mixture of (6) (1.12 g, 2.26 mmol), freshly distilled SOCl2 (5.38 g, 45.2 mmol), and n class="Disease">dry DMF (87 μ L, 1.13 mmol) were refluxed in dry CH2Cl2 (50 mL) under an inert atmosphere for 2 h. After evaporation and pumping for 2 h, the brown oil formed was re-dissolved in dry CH2Cl2 (25 mL) and NEt3 (2.00 mL) was added. This mixture was refluxed and a solution of dry CH2Cl2 (25 mL) containing (13) (536 mg, 8.17 mmol) was added dropwise over a period of 30 min. The resulting solution was kept under reflux for 16 h. and evaporated. The brown residue was re-dissolved in CH2Cl2 (100 mL) and washed with half-saturated NH4Cl solution (100 mL). After separation, the aqueous phase was extracted with CH2Cl2 (2 × 100 mL). The combined organic phases were dried over Na2SO4 and evaporated. The crude material was purified by column chromatography (silica gel, CH2Cl2/MeOH 99:1 → CH2Cl2/MeOH 95:5) to afford brown oil (725 mg, 79% yield). 1H NMR (400 MHz, 433 K, DMSO-d6) δ (ppm): 1.28 (t, 3J = 6.8 Hz, 3H, OCH2CH3), 3.27 (s, 3H, OCH3), 3.28 (s, 6H, OCH3), 3.39 (s, 3H, NCH3), 3.40 (s, 3H, NCH3), 3.40 (m, 4H, NCH2CH2), 3.45–3.50 (m, 14H, OCH2), 3.51–3.58 (m, 12H, OCH2), 3.61 (m, 2H, OCH2), 3.80 (m, 2H, OCH2), 4.17 (s (broad), 2H, CH2), 4.23 (q, 3J = 6.8 Hz, 2H, OCH2CH3), 4.33 (m, 2H, OCH2), 7.38 (d, 4J = 2.4 Hz, 1H, HPy.), 7.43 (d, 4J = 2.4 Hz, 2H, HPy.), 7.45–7.52 (d, 3J = 8.2 Hz, 3H, HBenz.), 7.80 (d, 3J = 8.2 Hz, 1H, HPy.), 7.86 (s, 1H, HBenz.), 7.91 (s, 1H, HBenz.), 8.23 (dd, 3J = 8.2 Hz, 4J = 1.7 Hz, 1H, HPy.), 8.64 (s, 1H, HPy.). 13C NMR (800 MHz, 327 K, DMSO-d6) δ (ppm): 13.66 (OCH2CH3), 37.45 (NCH3), 38.27 (NCH3), 47.23 (NCH2CH2), 47.39 (CH2), 57.81 (OCH3), 60.79 (OCH2CH3), 68.03 (OCH2), 68.24 (OCH2), 68.33 (OCH2), 68.47 (OCH2), 69.39 (OCH2), 69.42 (OCH2), 69.57 (OCH2), 69.81 (OCH2), 71.09 (OCH2), 111.83 (CHPy.), 112.76 (CHPy.), 123.88 (CHBenz.), 124.82 (CHBenz.), 125.18 (CHPy.), 131.12 (CHBenz.), 131.19 (CHBenz.), 134.38 (CHBenz.), 134.50 (CHBenz.), 135.20 (CBenz. quat.), 135.76 (CHPy.), 136.21 (CBenz. quat.), 136.68 (CHPy.), 140.50 (CBenz. quat.), 141.39 (CBenz. quat.), 145.03 (CBenz. quat.), 145.77 (CPy. quat.), 145.77 (CBenz. quat.), 147.62 (CPy. quat.), 153.67 (CPy. quat.), 155.07 (CPy. quat.), 163.58 (CONMe.), 165.30 (CONMe), 165.78 (COOEt), 166.50 (CPy. −O quat.). ESI-MS m/z calcd for [M + H+] (found): 1132.44 (1132.28); calcd for [M + 2H+]/2 (found): 566.72 (566.76).

Ethyl 6-[5-({2-[5-(bis{2-[2-(2-methoxyethoxy)ethoxy]ethyl}sulfamoyl)pyridin-2-yl]-1-methyl-1H-benzimidazol-5-yl}methyl)-1-methyl-1H-benzimidazol-2-yl]-4-{2-[2-(2-methoxyethoxy)ethoxy]ethoxy}pyridine-2-carboxylate (15)

Freshly activated iron powder (1.07 g, 19.1 mmol) and n class="Chemical">HCl (1.35 mL, 25%) were added to an EtOH/H2O solution (125/31 mL) containing (15) (720 mg, 0.636 mmol). The mixture was refluxed under an inert atmosphere for 16 h. The solution was cooled, the excess of un-reacted iron filtered, and evaporated. The crude product was re-dissolved in absolute EtOH (30 mL); H2SO4 (2 mL, 97%) was added carefully and the solution was refluxed overnight. It was cooled and the solvents were evaporated. Distilled water (100 mL) was added and the pH was adjusted to 6 with an aqueous saturated solution of NaHCO3. Na2EDTA (4.74 g, 12.7 mmol) was added to this solution, followed by H2O2 (1.5 mL, 30%), which resulted in the solution turning brown. The pH was then increased to 7 with a saturated solution of aqueous NaHCO3 before extraction with CH2Cl2 (5 × 100 mL). The organic phases were combined, dried over Na2SO4, filtered, and evaporated to dryness, resulting in a brown crude solid which was purified by column chromatography (silica gel; CH2Cl2 → CH2Cl2/MeOH 95:5) to give a pale yellow solid (585 mg, 89% yield). 1H NMR (400 MHz, 298 K, acetone-d6) δ (ppm): 1.42 (t, 3J = 7.2 Hz, 3H, OCH2CH3), 3.25 (s, 3H, OCH3), 3.26 (s, 6H, OCH3), 3.43 (m, 4H, NCH2CH2), 3.44 (m, 2H, OCH2), 3.50–3.55 (m, 12H, OCH2), 3.56–3.62 (m, 8H, OCH2), 3.65–3.70 (m, 6H, OCH2), 3.93 (m, 2H, OCH2), 4.29 (s (broad), 2H, CH2), 4.35 (s, 3H, NCH3), 4.41 (s, 3H, NCH3), 4.42 (q, 3J = 6.8 Hz, 2H, OCH2CH3), 4.45 (m, 2H, OCH2), 7.31 (dd, 3J = 8.5 Hz, 4J = 1.4 Hz, 1H, HBenz.), 7.35 (dd,3J = 8.8 Hz, 4J = 1.4 Hz, 1H, HBenz.), 7.53 (d,3J = 8.5 Hz, 1H, HBenz.), 7.55 (d, 3J = 8.8 Hz, 1H, HBenz.), 7.65 (d, 4J = 1.4 Hz, 1H, HBenz.), 7.68 (d, 4J = 1.4 Hz, 1H, HBenz.), 7.68 (d, 4J = 2.4 Hz, 1H, HPy.), 8.14 (d, 4J = 2.4 Hz, 1H, HPy.), 8.40 (dd, 3J = 8.5 Hz, 4J = 2.4 Hz, 1H, HPy.), 8.60 (d, 3J = 8.5 Hz, 1H, HPy.), 9.12 (d, 4J = 2.4 Hz, 1H, HPy.). 13C NMR (800 MHz, 298 K, CDCl3) δ (ppm): 14.42 (OCH2CH3), 33.12 (NCH3), 33.26 (NCH3), 42.36 (CH2), 48.37 (NCH2CH2), 59.18 (OCH3), 59.21 (OCH3), 62.01 (OCH2CH3), 68.34 (OCH2), 69.35 (OCH2), 69.80 (OCH2), 70.51 (OCH2), 70.62 (OCH2), 70.65 (OCH2), 70.75 (OCH2), 70.79 (OCH2), 71.09 (OCH2), 72.02 (OCH2), 70.05 (OCH2), 110.19 (CHBenz.), 110.23 (CHBenz.), 111.93 (CHPy.), 113.53 (CHPy.) 120.01 (CHBenz.), 120.29 (CHBenz.), 124.34 (CHBenz.), 125.22 (CHPy.), 125.85 (CHPy.), 135.61 (CHPy.), 136.08 (CBenz. quat.), 136.25 (CBenz. quat.), 136.53 (CBenz. quat.), 137.06 (CBenz. quat.), 142.76 (CPy. quat.), 143.01 (CBenz. quat.), 147.17 (CPy. quat.), 148.64 (CPy. quat.), 148.75 (CPy. quat.), 149.49 (CBenz. quat.), 152.42 (CBenz. quat.), 153.71 (CBenz. quat.), 165.05 (COOEt), 166.50 (CPy.−O quat.). ESI-MS m/z calcd for [M + H+] (found): 1036.47 (1036.25); calcd for [M + 2H+]/2 (found): 518.74 (518.86).

6-[5-({2-[5-(bis{2-[2-(2-methoxyethoxy)ethoxy]ethyl}sulfamoyl)pyridin-2-yl]-1-methyl-1H-benzimidazol-5-yl}methyl)-1-methyl-1H-benzimidazol-2-yl]-4-{2-[2-(2-methoxyethoxy)ethoxy]ethoxy}pyridine-2-carboxylic acid (HL5)

Intermediate (16) (575 mg, 5.56 × 10−1 mmol) was dissolved in an absolute EtOH/n class="Chemical">H2O solution (20/5 mL) containing NaOH (26.7 mg, 0.667 mmol). This mixture was stirred at 60°C for 16 h. After completion of the reaction, the solvents were evaporated. The residue was dissolved in distilled water (50 mL) and the resulting aqueous solution was acidified to pH = 2 by addition of 0.02 M hydrochloric acid. The acidic solution was then extracted with CH2Cl2 (5 × 100 mL), dried over Na2SO4, and evaporated. The crude product was triturated with hexane (100 mL), filtered and dried under vacuum to give a pale yellow solid (560 mg, 100% yield). 1H NMR (400 MHz, 298 K, acetone-d6) δ (ppm): 3.25 (s, 9H, OCH3), 3.43 (m, 4H, NCH2CH2), 3.45 (m, 2H, OCH2), 3.50–3.54 (m, 12H, OCH2), 3.55–3.62 (m, 8H, OCH2), 3.65–3.70 (m, 6H, OCH2), 3.93 (m, 2H, OCH2), 4.29 (s (broad), 2H, CH2), 4.33 (s, 3H, NCH3), 4.35 (s, 3H, NCH3), 4.47 (m, 2H, OCH2), 7.31 (dd, 3J = 8.5 Hz, 4J = 1.4 Hz, 1H, HBenz.), 7.34 (dd, 3J = 8.5 Hz, 4J = 1.4 Hz, 1H, HBenz.), 7.53 (d, 3J = 8.5 Hz, 1H, HBenz.), 7.55 (d, 3J = 8.5 Hz, 1H, HBenz.), 7.65 (d, 4J = 1.4 Hz, 1H, HBenz.), 7.68 (d, 4J = 1.4 Hz, 1H, HBenz.), 7.68 (d, 4J = 2.4 Hz, 1H, HPy.), 8.14 (d, 4J = 2.4 Hz, 1H, HPy.), 8.40 (dd, 3J = 8.2 Hz, 4J = 2.4 Hz, 1H, HPy.), 8.60 (d, 3J = 8.2 Hz, 1H, HPy.), 9.12 (d, 4J = 2.4 Hz, 1H, HPy.). 13C NMR (800 MHz, 298 K, CDCl3) δ (ppm): 32.80 (NCH3), 33.29 (NCH3), 42.33 (CH2), 48.39 (NCH2CH2), 59.18 (OCH3), 59.20 (OCH3), 68.67 (OCH2), 69.24 (OCH2), 69.80 (OCH2), 70.51 (OCH2), 70.62 (OCH2), 70.65 (OCH2), 70.74 (OCH2), 70.78 (OCH2), 71.11 (OCH2), 72.02 (OCH2), 72.03 (OCH2), 110.27 (CHBenz.), 110.31 (CHBenz.), 111.38 (CHPy.), 113.85 (CHPy.), 120.02 (CHBenz.), 120.23 (CHBenz.), 124.35 (CHBenz.), 125.58 (CHPy.), 125.86 (CHPy.), 135.64 (CBenz. quat.), 135.71 (CHPy.), 136.12 (CPy. quat.), 136.25 (CHPy.), 136.98 (CBenz. quat.), 139.42 (CBenz. quat.), 142.44 (CBenz. quat.), 142.95 (CBenz. quat.), 147.18 (CPy. quat.), 148.68 (CPy. quat.), 149.12 (CBenz. quat.), 150.54 (CPy. quat.), 153.62 (CBenz. quat.), 164.90 (COOH), 167.29 (CPy−O quat.). ESI-MS m/z calcd for [M + H+] (found): 1008.44 (1008.29); calcd for [M + 2H+]/2 (found): 504.72 (504.87). Anal. Calcd for C49H65N7O14S·H2O (found): C, 57.39 (57.14); H, 6.58 (6.65); N, 9.56 (9.29).

Analytical and spectroscopic measurements

Elemental analyses were performed by Dr. E. Solari, Elementary Analysis Laboratory of the Institute of Chemical Sciences and Engineering, EPFL. NMR spectra were measured on Bruker Avance DRX 400 (n class="Chemical">1H, 400 MHz), AV 600 (13C, 150.864 MHz), and AV 800 (13C, 201.54 MHz) spectrometers. Spectra of organic compounds were recorded in CDCl3 (99.8%), CD3CN (99.8%), acetone-d6 (99.5%), DMSO-d6 (99.8%), and D2O (99.9%), all from Aldrich Chemicals. Deuterated solvents were taken as internal standards; chemical shift values are given in ppm with respect to TMS and J values are reported in Hz. The ESI-MS spectra of the organic compounds were obtained on a Finningan TSQ 7100 spectrometer using 10−5–10−4 M solutions in acetonitrile/H2O/formic acid (49.5/49.5/1) or MeOH; the capillary temperature was set to 180°C and the ion spray voltage to 3.5 kV. The instrument was calibrated using horse myoglobin and the analyses were conducted in positive mode. Phosphoric acid was used for mass calibration in the range 500–2000 m/z. Data were acquired and processed with Masslynx version 4.0. Electrospray conditions were as follows: capillary voltage, 3 kV; source temperature, 80°C; cone voltage, 35 V; source block temperature, 150°C. The ESI nebulization and drying gas was nitrogen. The sample was introduced through a syringe pump operating at 20 μ L·min−1. Simulation of spectra was achieved with Molecular Weight Calculator 6.42®. UV/Vis absorption spectra were measured in 1.0 cm quartz Suprasil® cells on a Perkin-Elmer Lambda 900 spectrometer. Stability constants were determined by spectrophotometric titration of (L4,5)− by EuIII or EuIII/ZnII (1:1) in Tris-HCl 0.1 M (pH 7.4) under N2 atmosphere. All titrations were performed batch wise in thermostated (25.0 ± 0.1°C) 1-cm quartz cuvettes. Factor analysis (Malinowski and Howery, 1991) and mathematical treatment of the spectrophotometric data were performed with the Specfit® software (Gampp et al., 1986). Luminescence spectra and lifetimes were collected either on a Horiba-Jobin Yvon FL 3-22 fluorometer or on a home-made high-resolution set-up, according to procedures published previously (Rodriguez-Cortinas et al., 2002). Quantum yields were measured by an absolute method using a specially designed integration sphere (Aebischer et al., 2009).

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.